167 related articles for article (PubMed ID: 20812217)
1. Cell-based hepatitis C virus infection fluorescence resonance energy transfer (FRET) assay for antiviral compound screening.
Yu X; Uprichard SL
Curr Protoc Microbiol; 2010 Aug; Chapter 17(1):Unit 17.5.. PubMed ID: 20812217
[TBL] [Abstract][Full Text] [Related]
2. Development of a cell-based hepatitis C virus infection fluorescent resonance energy transfer assay for high-throughput antiviral compound screening.
Yu X; Sainz B; Uprichard SL
Antimicrob Agents Chemother; 2009 Oct; 53(10):4311-9. PubMed ID: 19620334
[TBL] [Abstract][Full Text] [Related]
3. Identification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assay.
Yu X; Sainz B; Petukhov PA; Uprichard SL
Antimicrob Agents Chemother; 2012 Dec; 56(12):6109-20. PubMed ID: 22948883
[TBL] [Abstract][Full Text] [Related]
4. A time-resolved fluorescence-resonance energy transfer assay for identifying inhibitors of hepatitis C virus core dimerization.
Kota S; Scampavia L; Spicer T; Beeler AB; Takahashi V; Snyder JK; Porco JA; Hodder P; Strosberg AD
Assay Drug Dev Technol; 2010 Feb; 8(1):96-105. PubMed ID: 20035614
[TBL] [Abstract][Full Text] [Related]
5. Development of a multiplex phenotypic cell-based high throughput screening assay to identify novel hepatitis C virus antivirals.
Kim HY; Li X; Jones CT; Rice CM; Garcia JM; Genovesio A; Hansen MA; Windisch MP
Antiviral Res; 2013 Jul; 99(1):6-11. PubMed ID: 23660623
[TBL] [Abstract][Full Text] [Related]
6. Development of robust in vitro serine protease assay based on recombinant Pakistani HCV NS3-4A protease.
Fatima K; Tahir M; Qadri I
Virus Res; 2011 Sep; 160(1-2):230-7. PubMed ID: 21756947
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity.
Gentzsch J; Hinkelmann B; Kaderali L; Irschik H; Jansen R; Sasse F; Frank R; Pietschmann T
Antiviral Res; 2011 Feb; 89(2):136-48. PubMed ID: 21167208
[TBL] [Abstract][Full Text] [Related]
8. A cell-based beta-lactamase reporter gene assay for the identification of inhibitors of hepatitis C virus replication.
Zuck P; Murray EM; Stec E; Grobler JA; Simon AJ; Strulovici B; Inglese J; Flores OA; Ferrer M
Anal Biochem; 2004 Nov; 334(2):344-55. PubMed ID: 15494142
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel anti-hepatitis C virus agents by a quantitative high throughput screen in a cell-based infection assay.
Hu Z; Hu X; He S; Yim HJ; Xiao J; Swaroop M; Tanega C; Zhang YQ; Yi G; Kao CC; Marugan J; Ferrer M; Zheng W; Southall N; Liang TJ
Antiviral Res; 2015 Dec; 124():20-9. PubMed ID: 26515788
[TBL] [Abstract][Full Text] [Related]
10. Development of a fluorescence resonance energy transfer-based intracellular assay to identify novel enterovirus 71 antivirals.
Lu WW; Kung FY; Deng PA; Lin YC; Lin CW; Kung SH
Arch Virol; 2017 Mar; 162(3):713-720. PubMed ID: 27873071
[TBL] [Abstract][Full Text] [Related]
11. High-throughput screening of low molecular weight NS3-NS4A protease inhibitors using a fluorescence resonance energy transfer substrate.
Sudo K; Yamaji K; Kawamura K; Nishijima T; Kojima N; Aibe K; Shimotohno K; Shimizu Y
Antivir Chem Chemother; 2005; 16(6):385-92. PubMed ID: 16329285
[TBL] [Abstract][Full Text] [Related]
12. Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.
Vausselin T; Séron K; Lavie M; Mesalam AA; Lemasson M; Belouzard S; Fénéant L; Danneels A; Rouillé Y; Cocquerel L; Foquet L; Rosenberg AR; Wychowski C; Meuleman P; Melnyk P; Dubuisson J
J Virol; 2016 Oct; 90(19):8422-34. PubMed ID: 27412600
[TBL] [Abstract][Full Text] [Related]
13. Screening of hepatitis C virus inhibitors using genotype 1a HCV replicon cell lines.
Robinson M; Tian Y; Pagratis N; Delaney WE
Curr Protoc Microbiol; 2011 Aug; Chapter 17():Unit17.7. PubMed ID: 21805689
[TBL] [Abstract][Full Text] [Related]
14. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
J Virol; 2019 May; 93(10):. PubMed ID: 30842319
[TBL] [Abstract][Full Text] [Related]
15. Establishment and application of high throughput screening model for hepatitis C virus NS3-4A protease inhibitors in vitro.
Jian-rui L; Yan-bin W; Shu-yi S; Hong-shan C; Jian-dong J; Zong-gen B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Feb; 33(1):98-101. PubMed ID: 21375947
[TBL] [Abstract][Full Text] [Related]
16. Novel cell-based hepatitis C virus infection assay for quantitative high-throughput screening of anti-hepatitis C virus compounds.
Hu Z; Lan KH; He S; Swaroop M; Hu X; Southall N; Zheng W; Liang TJ
Antimicrob Agents Chemother; 2014; 58(2):995-1004. PubMed ID: 24277038
[TBL] [Abstract][Full Text] [Related]
17. Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assay.
O'Boyle DR; Nower PT; Lemm JA; Valera L; Sun JH; Rigat K; Colonno R; Gao M
Antimicrob Agents Chemother; 2005 Apr; 49(4):1346-53. PubMed ID: 15793110
[TBL] [Abstract][Full Text] [Related]
18. Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents.
Buckwold VE; Beer BE; Donis RO
Antiviral Res; 2003 Sep; 60(1):1-15. PubMed ID: 14516916
[TBL] [Abstract][Full Text] [Related]
19. A Novel Small Molecule Inhibits Hepatitis C Virus Propagation in Cell Culture.
Oraby AK; Gardner CL; Needle RF; Kofahi HM; Everard KR; Taylor NGA; Rutihinda SG; Barry JP; Hirasawa K; Georghiou PE; Russell RS
Microbiol Spectr; 2021 Sep; 9(1):e0043921. PubMed ID: 34319169
[TBL] [Abstract][Full Text] [Related]
20. Antiviral stilbene 1,2-diamines prevent initiation of hepatitis C virus RNA replication at the outset of infection.
Gastaminza P; Pitram SM; Dreux M; Krasnova LB; Whitten-Bauer C; Dong J; Chung J; Fokin VV; Sharpless KB; Chisari FV
J Virol; 2011 Jun; 85(11):5513-23. PubMed ID: 21430055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
